Edgewise Therapeutics Inc. Common Stock vs Guidewire Software Inc. Common Stock — how do they compare? Edgewise Therapeutics Inc. Common Stock trades at $37.11 (market cap $4.02B), while Guidewire Software Inc. Common Stock trades at $163.81 (market cap $13.52B). The key difference: Guidewire Software Inc. Common Stock is far larger — about 3.4× Edgewise Therapeutics Inc. Common Stock's market cap, and Edgewise Therapeutics Inc. Common Stock is trading nearer its 52-week high, Guidewire Software Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Edgewise Therapeutics Inc. Common Stock for 0 Days and Guidewire Software Inc. Common Stock for 0 Days on average.
| EWTX | GWRE | |
|---|---|---|
Market Cap | $4.02B | $13.52B |
Volume | 1,446,128 | 897,708 |
Sector | Health | Technology |
52-Week High | $48.35 | $254.23 |
52-Week Low | $14.89 | $102.69 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $3.56B | $13.48B |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Edgewise Therapeutics, Inc. is a clinical-stage biopharmaceutical company that develops small-molecule therapies based on its research in muscle physiology, with a pipeline focused on cardiovascular and cardiometabolic conditions such as hypertrophic cardiomyopathy and heart failure.
Read more on EWTX →Guidewire Software Inc. develops InsuranceSuite Cloud, a software platform used by property and casualty insurers for policy administration, billing, and claims processing.
Read more on GWRE →